IGF-1 LR3

0.1mg · Lyophilized Powder · 9,117.5 Da

$60.00 CAD

IGF-1 LR3 is a synthetic analogue of insulin-like growth factor-1 engineered with a 13-amino-acid N-terminal extension and a glutamic acid substitution at position 3 that dramatically reduces binding to IGF-binding proteins (IGFBPs). This modification extends the peptide's half-life from minutes (native IGF-1) to approximately 20–30 hours, enabling once-daily dosing in research protocols. By remaining bioavailable in circulation longer, IGF-1 LR3 exerts sustained anabolic and metabolic effects through IGF-1 receptor signalling.

Research Applications

•IGF-1 receptor activation with extended bioavailability research

•Protein synthesis and lean mass support research via anabolic signalling

•Glucose uptake and insulin sensitivity research

•Tissue repair and satellite cell activation research

•Reduced IGFBP binding and enhanced systemic IGF-1 activity research

•Comparative research versus native IGF-1 pharmacokinetics

VIAL0.1 mg (100 mcg)

PURITY≥99% (HPLC)

FORMLyophilized powder

STORAGE-20°C lyophilized / 2-8°C reconstituted

RECON1.0 mL BAC water

USEResearch only

VIEW DOSING PROTOCOL →

All products sold by JA Performance Peptides are intended strictly for laboratory research purposes and are not approved for human consumption, veterinary use, or therapeutic application. Not for human use.